Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations
Early Phase 1
Active, not recruiting
- Conditions
- Influenza A
- Interventions
- Biological: Influenza Fluzone vaccine
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- La Jolla Institute for Immunology
- Target Recruit Count
- 23
- Registration Number
- NCT06567860
- Locations
- 🇺🇸
La Jolla Institute for Immunology, La Jolla, California, United States
© Copyright 2025. All Rights Reserved by MedPath